|
|
------------------------------------------------------------------------Contents (.PDF) Federal RegisterContents (.TXT) Vol. 64, No.22Wednesday, February 3, 1999------------------------------------------------------------------------RULESNADA 095-735, CVM9826. New Animal Drugs for Use in Animal Feeds; Monensin. Pages 5158-5160 [FR Doc. 99-2507 [TXT] [PDF] Freedom of Information SummaryDocket No. 99F-0126, CFSAN992. Ciba Specialty Chemicals Corp.; Filing of Food Additive Petition. Pages 5299-5300 [FR Doc. 99-2506] [TXT] [PDF] Docket No. 99F-0127, CFSAN98242. GEO Specialty Chemicals; Filing of Food Additive Petition. Page 5300 [FR Doc. 99-2505] [TXT] [PDF] Docket No. 91N-0396, OC9924. Agency Information Collection Activities; Announcement of OMB Approval; Medical Devices; Reports of Corrections and Removals. Page 5300 [FR Doc. 99-2563] [TXT] [PDF] Supporting StatementDocket No. 98D-1232, CDRH98129. Points To Consider Guidance Document on Assayed and Unassayed Quality Control Material; Draft; Availability. Pages 5300-5301 [FR Doc. 99-2508] [TXT] [PDF] Written comments by May 4, 1999. Draft GuidanceDocket No. 98D-1224, CDER98100. Guidance for Industry on FDA Approval of New Cancer Treatment Uses for Marketed Drug and Biological Products; Availability. Pages 5301-5302 [FR Doc. 99-2562] [TXT] [PDF] The GuidanceDocket No. 98D-0375, CDRH98100. Guidance for Staff, Industry and Third Parties: Third Party Programs Under the Sectoral Annex on Medical Devices to the Agreement on Mutual Recognition Between the United States of America and the European Community; Availability. Pages 5302-5303 [FR Doc. 99-2509] [TXT] [PDF] The Guidance |